Govt suggests imposing anti-dumping duty on a pharma API from China
The recommended duty is USD 12.91 per kg.;
Advertisement
New Delhi: The commerce ministry has recommended imposition of anti-dumping duty on a pharma raw material - Ceftriaxone Sodium Sterile - from China to guard domestic players from cheap imports.
The commerce ministry's investigation arm Directorate General of Trade Remedies (DGTR) has recommended the duty after concluding in its probe that the API (active pharma ingredient) from China has been exported at dumped prices into India, which impacted the domestic industry.
"The authority recommends the imposition of the anti-dumping duty on the imports of subject goods...," the directorate has said in a notification.
Ceftriaxone Sodium Sterile is an API used in formulation for treating disease like lower respiratory tract infection, skin and skin structure infection, and surgical prophylaxis.
DGTR had conducted the probe following a complaint from Nectar Life Sciences and Sterile India about the dumping of the chemical.
"The recommended duty is USD 12.91 per kg. The finance ministry takes the final decision to impose duty," reports PTI.
In a separate notification, DGTR has said it has started a sunset review probe to review the need for continued imposition of anti-dumping duties on aluminium foil from China.
The imposition of anti-dumping duty is permissible under the World Trade Organisation (WTO) regime.
The duty is aimed at ensuring fair trading practices and creating a level-playing field for domestic producers vis-a-vis foreign producers and exporters.
Medical Dialogues team had earlier reported that the DGTR had recommended the imposition of anti-dumping duty on Vitamin C, used by pharmaceutical firms for medicine production, from China to guard domestic manufacturers from cheap imports.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.